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Early developments
Radiosurgery in its early development was considered to
be a surgical technique for treating a sharply defined
lesion in the brain by focusing a high single dose of
radiation from external sources onto the target lesion.
A narrow radiation beam became in effect a new surgical
tool but unlike ‘real surgery’ was a non-invasive technique.
The Gamma Unit (it was only later called the Gamma
Knife) was developed by the pioneer Swedish neuro-
surgeon Lars Leksell with the aim of avoiding the
necessity of trephining the skull and the consequent risk
of infection or intracranial bleeding. In Leksell’s own
words [1] when he lectured on deep brain surgery at the
50th anniversary meeting of the Harvey Cushing Society
in 1981.
‘Surgery is a conservative art. The skull has been
trephined since the Stone Age 
and many of our neurosurgical instruments are almost
as ancient. Modern brain surgery 
became possible when new and fresh tools were
provided. New developments in physics 
and engineering may allow more radical changes in the
old surgical handicraft’.
Radiosurgery was initially employed in the field of
functional neurosurgery for the treatment of pain,
psychosis and movement disorders. In following years its
use was extended to the treatment of diseases such as
arteriovenous malformations (AVMs) and intracranial
tumours. This led to a change of the original definition of
radiosurgery and cranial radiosurgery is now considered
to be an irradiation procedure for producing a required
radiobiological effect (vessel obliteration, tumour control)
by focusing radiation from external sources into
a stereotactically defined cerebral lesion. Hence the term
stereotactic radiosurgery (SRS). In SRS the aim is to
deliver a dose to the treatment volume in order to
produce necrosis. Two main requirements are essential.
Firstly, the precise spatial definition of the target and
secondly, a steep fall-off of the absorbed dose at the edges
of the target volume.
SRS and its possible general applications were first
described in 1949 by Lars Leksell [2, 3] who used
a stereotactic frame and moved a 280 kV X-ray source
along an arc. The target was precisely located at the
geometrical centre of the arc. At this focal point the
radiation dose was accumulated by so-called geometrical
focusing. This first apparatus was employed for precise
irradiation of the gasserian ganglion in cases of trigeminal
neuralgia. However, owing to the high scatter fraction of
the low energy X-rays, the procedure would have been
better performed using high energy particles.
SRS using protons
In 1958-1960 in a series of animal experiments, Börje
Larson et al [5, 6] studied the effect of 185 MeV protons
on cerebral tissue. This method was applied on a selected
number of patients in which a small, well demarcated
lesion was obtained in the thalamic nuclei for treatment
of movement disorders and intractable pain [7, 8].
Meanwhile other investigators used the end range of the
proton or helium ion beam, the Bragg peak. In this region
of the beam, the ionising effect is several (usually 4-5)
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times greater than elsewhere; a great sparing effect can be
obtained: physical focusing.
Unfortunately, the area of the edge of the beam is
narrow where energy delivery is highest and clinical use
requires a spread of the ionisation obtained by the use of
variable absorbers. However, this artifice reduces the gain
between the region of Bragg peak and the rest of the
intracranial beam path. Crossfire of 4-12 beams into the
target was normally required to achieve an adequate dose
fall-off outside the target.
In 1959, Raymond Kjellberg [9] initiated a study
using Bragg peak proton beam irradiation at the Harvard
186 MeV cyclotron unit. The pituitary gland was selected
first as a suitable target. However, no matter how success-
ful, heavy ion irradiation proved to be cumbersome, from
both technical and logistic reasons. The latter were
particularly difficult for the Swedish patients, who after
stereotactic study performed in Stockholm, had to be
transported (whilst wearing the stereotactic frame) to
Uppsala for irradiation. This was a 150 km journey.
SRS using 60Cobalt gamma rays
Trying to overcome the problems encountered with
proton SRS, Lars Leksell and his colleagues developed in
1967 the first stereotactic irradiation apparatus specifically
designed to perform SRS treatment of intracranial targets
[10]. This was the Gamma Unit I. In this device an array
of 60Cobalt sources, distributed over a spherical sector
of 70° x 160° allowed simultaneous crossfire with 170
separated beams with both high mechanical precision
and physical reproducibility [11].
This Gamma Unit I was initially used mainly to treat
pain. Due to the knowledge gained with gamma
thalamotomy [12] the first studies were made of
radiobiological problems of large doses delivered in
a single SRS treatment session. Nowadays there is no
doubt that SRS finds its major application in the
treatment of intracranial tumours and vascular
malformations, for which the Gamma Unit I proved to be
inadequate. In 1975 the Gamma Unit II was introduced
[11] with increased diameter circular collimators of 8 mm
and 14 mm in order to permit irradiation of larger targets.
By the 1970s Lars Leksell and his colleagues had
demonstrated the efficacy of the Gamma Unit II
(Figure 1) for the treatment of solid craniopharyngiomas
[13], pinealomas, pituitary adenomas [14] and acoustic
neuromas [15]. Also Ladislau Steiner et al [16] had
performed the first successful obliteration of an
inoperable cerebral AVM. Then in July 1979, during
a meeting in Paris on stereotactic cerebral SRS, the
Swedish school, led by Lars Leksell, and the American
school represented by Raymond Kjellberg, presented
such an impressive collection of clinical results that
seemed to leave very few in doubt concerning the
important role that SRS would occupy in the future.
During this pioneering era, SRS was restricted to
only a few centres employing various dedicated apparatus
such as a Gamma Unit or a cyclotron. Nevertheless,
experience was accumulated and the number of
candidates for SRS steadily increased. However, although
many neurosurgeons had the technical expertise and
theoretical knowledge to use SRS procedures, few of
them had the possibility to overcome the financial
Figure 1. Sketch of the prototype for the Leksell Gamma Knife. (1) Protective housing. (2) In all,
279 60Cobalt sources 1 mm diameter, distributed over a spherical sector. (3) Primary collimators.
(4) Secondary collimators (exchangeable) mounted on the treatment table. (5) Sliding treatment
table with stereotactic adjustment of patient position. (6) Folding protection barrier. 
Courtesy Professor Rune Walstam [46]
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problems related to the acquisition of a Gamma Unit or
cyclotron. Barcia Salorio [17] was the first to try to bypass
these financial problem by using a standard 60Cobalt
teletherapy unit under stereotactic conditions in order
to irradiate acoustic tumors and carotid cavernous
fistulae.
SRS using X-rays from linear accelerators
In a 1971 monograph, Lars Leksell [10] considered the
possibility of employing a linear accelerator but concluded
that the final choice of gamma rays rather than high
energy X-rays from linear accelerators was determined
on technical grounds and on the need for a practical
and reliable clinical method. Notwithstanding this
authoritative warning, the advent of linear accelerator
based SRS was imminent and the first report of a linear
accelerator based SRS technique was published in 1983 by
Betti & Derechinsky [18]. In its early version the
procedure employed a number of isocentric fixed
radiation fields in different planes obtained by the
rotation of patient's head around a transverse axis.
In 1985 Federico Colombo et al [19] published our
technique which was based on multiple converging arc
irradiations (Figure 2). A similar technique was reported
independently by Gunther Hartmann et al [20]. In the
Colombo et al method [19] as in most linear accelerator
based SRS techniques, the dose delivery inside the target
volume is obtained by using multiple, non-coplanar, arc
irradiations. The stereotactically defined target is made to
coincide with the linear accelerator isocentre and a single
arc irradiation is performed. The target is then rotated
around a vertical axis which passes through the isocentre
and arc irradiations are repeated in different angular
positions which are distributed using a dihedral angle.
Recent interest in linear accelerator based SRS has
provided an impetus for neurosurgeons, radiation
oncologists and medical physicists to become more
involved in this treatment technique. Starting from the
basic idea of rotational radiation therapy using moving
beam techniques, a variety of ideas have been proposed
and tested in clinical practice [21-24] and currently there
are more than 1,000 centres utilising a linear accelerator
for SRS.
Indications for cranial SRS
In its original version SRS was intended as a means of
obtaining the destruction of small volume of precisely
located nervous tissue for the purpose of functional
neurosurgical treatment. In the early years, the indications
for SRS were only for those diseases which could be cured
by selective destruction of deep nervous structures [12,
24]. Functional SRS now enjoys a renaissance which we
believe has raised more enthusiasm than the results justify
[26-28].
Currently SRS finds its main application in the
treatment of organic diseases. The indications vary
according to the physical and pathological data. Because
of the steep dose fall-off which is achieved using SRS,
theoretically every lesion with clear-cut borders can be
selectively destroyed by an adequate radiation dose. For
this reason, benign tumours with non-infiltrating margins
[14, 15, 29-31] are thought to be better indications for
SRS than are infiltrating malignant lesions [32-34]. The
tolerance of neural tissue to single dose SRS definitely
depends on the target volume. The opinion that SRS, at
least when large single-shot doses are delivered, should be
restricted to volumes smaller than 10-15 cm3 has gained
some acceptance. SRS can also be more easily applied
to lesions with spherical geometry.
When Lars Leksell introduced radiosurgery, the idea
was to avoid the risks of craniotomy and from its
inception SRS found general acceptance when prescribed
Figure 2. A schematic diagram of the linear accelerator based SRS system used in San Bortolo
Hospital, Vicenza since 1982
for treating lesions in which standard craniotomy removal
was considered to be either dangerous or impossible.
Nowadays the indication for SRS is strongly influenced by
the results of microsurgery.
Indications for different SRS techniques can
sometimes be due to vague and not generally accepted
views. Thus for example, the Gamma Knife is considered
by some to be mechanically more accurate and more
appropriate to treat lesions very close to critical areas,
such as pituitary adenomas. Whereas the linear
accelerator is considered by some to permit the treatment
of larger volumes of tissue and can if required be
employed using multiple fractions. Consequently the
linear accelerator is considered by some to provide
a better indication for gliomas and other malignant
tumours. However, views change as technology evolves.
Evolution of the technique of cranial SRS
In its standard configuration, linear accelerator SRS using
fixed circular collimators is well suited for treatment of
spherical targets. In clinical practice, however, a perfect
spherical shape is more often the exception than the rule
and the target volume is often a 3D irregular shape. To try
to adapt a spherical isodose to a non-spherical target
means either choosing a radiation field which is too large
(i.e., giving an overdose to some normal tissues) or
choosing a radiation field which is too small (i.e., giving an
underdose to some tumour tissue).
Early efforts to treat non-spherical targets employed
multiple isocentres to try to conform the dose distribution
to the geometrical shape of the tumour/target volume.
This technique reduces the irradiation of normal tissue
but creates large regions of dose inhomogeneity and may
increase the risk of neurological complications. The first
attempt to solve this problem was to change the shape of
the isodose surfaces by changing the angular approach
and the weighting of arc irradiations. Some 3D treatment
planning software enables the simulation of different
irradiation alternatives by modifying previously defined
values for treatment parameters. It is then possible to
shape the isodose distributions in predetermined
directions so that they conform better to the treatment
volume. Isodose curve manipulation is easier to achieve
for lower isodoses of less than 50%. Consequently it has
been employed more frequently to increase the steepness
of the dose gradient adjacent to critical structures such as
optical anatomy and the brain stem.
In shaping isodose curves it is generally the case that
an increase in isodose gradient steepness in one direction
is accompanied by a decrease of gradient steepness in
another direction. The use of multiple fixed fields instead
of an arc (e.g., six fixed fields for each arc) permits the
field to be shaped according to the cross-section of the
lesion without increasing the risk of complications. The
contour of the lesion according to the beam’s eye view can
be directly extrapolated by using the treatment planning
system. Such a contour can be utilised with a multileaf
collimator system for obtaining a required beam shape.
A more up-to-date procedure is dynamic field
shaping. In this case the beam is made to conform to the
projected shape during each increment of the arc
irradiation. This solution requires a computer-driven
collimator that during rotation can accommodate the
contour of the beam according to the continually
changing cross-section of the irregular target volume. In
this case however, the mechanical complexity necessary to
continuously trim the field for each increment of the arc,
limits the possibility of very close correspondence between
the beam shape and target contour. Nevertheless a 25%
sparing of normal tissue has been reported.
Several techniques have been applied to provide an
improvement to the basic converging fields or converging
arc planning procedures. However certain isodose shape
modifications can be obtained more easily by considering
beam geometries which are different from arcs. The real
breakthrough for the treatment of 3D irregular targets
was to abandon isocentric treatments and to move to
scanning beam techniques. This is achieved either
(option 1) by applying special devices to existing linear
accelerators or (option 2) by moving to completely
different robotic apparatus [35]. In option 1 the
irradiation is performed by a rectilinear translation of
a narrow beam, devised to scan the treatment volume
slice by slice. For each slice the target is rotated with
respect to the source and the irradiation repeated from
different angular positions. A dose is delivered which is
proportional to the thickness of the target volume along
the beam axis. This is achieved either by modifying the
speed of the translation or by inserting a computerised
variable absorber. The advantage of the experimental
set-up is that it can be applied to every existing linear
accelerator. It consists of a motorised treatment couch
designed to move the patient along a predetermined
direction at a predetermined speed. In order to modulate
the dose, couch movement control can be simplified by
employing a variable absorber instead of the variable
speed of couch translation [35].
Option 2 is to become free from the mechanical
restriction of gantry-based systems by introducing robotics
and a lightweight narrow beam X-band linear accelerator
[36]. In this CyberKnife system the linear accelerator
always aims towards the target as it moves along different
trajectories around the patient via a computer-driven
robotic arm with six degrees of freedom. Standard
isocentric or non-isocentric beam techniques can be
accurately simulated using a 3D treatment planning
system, be thoroughly evaluated and when selected as
the most appropriate be accurately reproduced for
treatment. Moreover there is no need for a stereotactic
head frame. Two orthogonal X-ray assemblies are
arranged to define the position of the patient’s head in
the robot reference system by identifying the bony
profiles and comparing them with digitally reconstructed
images (DDRs) from CT data. Once the position of the
head is determined, the target is reconstructed from
recorded computerised examinations and its coordinates
transmitted to the robot movement control for aiming
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the beam. A similar procedure of image guidance is
employed in more conventional linear accelerator based
SRS systems [37].
Imaging advances represent an important
contribution to targeting accuracy in SRS and expand
the possibilities for SRS. The very first stereotactic
apparatus relied on X-ray projections for aiming at the
target. CT was only introduced later. It is important to
note that there are two reasons why CT data are essential
for SRS. Firstly, dose calculation algorithms rely on
information which can be found in CT datasets: namely
relative electron density of the medium. Secondly, CT is
the tomographic modality which offers the best spatial
accuracy: freedom from geometrical distortion as com-
pared to MRI. With its DRR method, the CyberKnife
system combines X-ray projections and CT for target
localisation. Nevertheless, other imaging modalities than
CT have become important for diagnostic purposes and
inevitably a need has arisen for the new datasets to be
incorporated into SRS planning systems. This integration
is made possible by image registration techniques, often
referred to as image fusion. MR is the most frequently
fused modality to CT. Even though the first applications
allowed only rigid movements to be performed, new
algorithms for image registration can offer different types
of deformation that at least in principle, could account for
image distortion. Recent applications open the way to
images which are unusual in SRS: PET, rotational
angiography and functional MRI [38, 39].
Treatment planning systems evolved from the point
of view of treatment optimisation. As techniques become
increasingly sophisticated, we need computer programmes
to fully exploit conformation capabilities: similar to
software used in intensity modulated radiation therapy.
The choice of the number and position of beams, is still
performed by the operator in many SRS techniques.
However, this is now giving way to inverse planning
techniques in which the operator makes decisions on
prescription and constraints, and the system itself explores
the set of possible solutions to find the optimised set-up.
The CyberKnife system, by exploiting this type of
optimisation strategy and by image guidance with the use
of a robotic arm has introduced two important features of
great clinical impact: dose fractionation and extracranial
radiosurgery.
Dose fractionation
Originally the aim of SRS in the field of functional
neurosurgery was to achieve necrosis of a small target
volume [12]. With this aim, no real advantage was to be
found in dose fractionation: a radiation therapy schedule
designed to increase tumour control and to decrease the
risk of radiation necrosis. This is the reason why, in the
early period, SRS was only performed with high single
doses. As target volumes changed from neural tissues to
AVMs and benign tumours, no benefit was perceived for
fractionation. In contrast the benefits of fractionated
regimens are well known in general radiotherapy when
dealing with highly proliferative tumours. Fractioned SRS
seems to be indicated when large target volumes are
involved (since fractionation reduces the risk of normal
tissue complications) and when tumours with high
proliferative rates are targeted [24, 31]. Intracranial SRS
hypofractionation with 3-5 fractions has been suggested
and employed as a means of treating larger target
volumes (40-50 cm3) than those usually treated by
radiosurgery. This is being employed more frequently as
a procedure to preserve important functions where the
integrity of involved critical structures is of paramount
importance. Two examples are hearing in acoustic
tumours, and visual acuity in cranial base meningiomas
[40, 41].
Extracranial SRS
A frameless SRS technology such as the CyberKnife
(Figure 3), allows ablation of targets anywhere within the
body. For intracranial targets a comparison between bony
profiles from DRRs and intraoperative X-rays is used
for stereotactic localisation to accurately position the
patient at the isocentre. This is achieved by matching the
bony skull based landmarks from CT based DRRs to
those captured by the orthogonal pair of digital X-ray
images. The patient is automatically repositioned until
a perfect match is made. For targets outside the skull
there is a need to define an intermediate spatial reference
system that is visible in CT and in conventional X-ray
images. For this purpose, before CT scanning usually 3-6
radio-opaque markers must be inserted into or close to
the tumour. These fiducials are clearly identifiable in
both image datasets. They define unequivocally a spatial
reference system that can be employed to transform
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Figure 3. Schematic overview of the Osaka University Medical Center
CyberKnife system. Infrared tracking is used to record external motion
of the patient’s abdominal and chest surface. Stereo X-ray imaging
with dual diagnostic energy X-ray sources is used to record the 3D
position of internal gold fiducial markers at fixed time intervals during
treatment. A robotic arm, with six degrees of freedom moves the 6 MV
X-band linear accelerator X-ray beam source to actively compensate
for respiratory motion [47]
target coordinates from CT to the robot’s reference
system [42].
Moreover, since fiducials are inserted into the
tumour or fixed to it, image guidance based on radio-
opaque markers (fiducial tracking) can also be employed
for beam aiming at tumours which move because of
respiratory activity in the lung or upper abdomen. In this
setting, X-ray imaging is used to accurately track periodic
movements connected with respiration and to precisely
relate it to the movement of external optical (LED)
sources secured to the chest wall. The robot is connected
to optical detectors that track the external markers and
anticipate the target shift by moving the beam
accordingly. The CyberKnife system periodically checks
whether the correlation model between internal markers
and optical sources is verified. That is, if the target is in
the verified position [43, 44].
Conclusions
Image guidance represents a key factor leading to
innovation in SRS. Excellent results which parallel those
already obtained by frame based SRS techniques have
been described for cranial SRS. A main advantage of
frameless SRS is the freedom from cranial screw fixation;
a procedure which is not easily tolerated by uncooperative
patients. Exciting new applications have now become
available in spinal SRS in the armamentarium of
neurosurgical procedures applicable in both benign
lesions (meningiomas, neuromas, AVMs) and malignant
lesions (primary and secondary malignant tumours of the
spine).
A more problematic use of SRS is in extracranial
applications. No matter how precisely focussed the
external irradiation by the image guided SRS apparatus,
one has to take into account the differences in the
biological characteristics of intended targets. For cranial
SRS the principal indications are well demarcated lesions.
Extracranial SRS has been employed so far for the
treatment of large (by cranial standards) malignant
tumours of the lung, pancreas, liver, kidney and prostate.
Phase 1 studies have been launched in a restricted
number of centres but follow-up is too short for collecting
any evidence of efficacy [45]. As neurosurgeons we are
now facing a rapid and revolutionary change in a field
which we considered to be exclusively our own. We must
now be prepared to share our knowledge and our space
with other specialties. We hope this will produce major
improvements in the treatment of some of the more
devastating non-CNS neoplasms.
Carlo Cavedon PhD
Department of Medical Physics
San Bortolo Hospital
Viale Rodolfi 37
36100 Vicenza
Italy
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